Covered recipient · General Payments record
KAZI ASIF HILMI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2021–2024
$2,535.00
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,018.23 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $499.35 | 4 |
| Amgen Inc. | $383.68 | 3 |
| Xeris Pharmaceuticals, Inc. | $368.99 | 3 |
| Abbott Laboratories | $163.35 | 1 |
| Insulet Corporation | $150.00 | 1 |
| DEXCOM, INC. | $144.01 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $124.73 | 1 |
| PFIZER INC. | $107.12 | 1 |
| CeQur Corporation | $77.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $163.35 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125362198 | CMS |
| Amgen Inc. | $124.89 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111599378 | CMS |
| Amgen Inc. | $124.97 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117579112 | CMS |
| Amgen Inc. | $133.82 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111599380 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $124.73 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086230458 | CMS |
| CeQur Corporation | $77.00 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126847608 | CMS |
| Dexcom, Inc. | $144.01 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153313487 | CMS |
| Insulet Corporation | $150.00 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116806668 | CMS |
| PFIZER INC. | $107.12 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131568056 | CMS |
| SANOFI-AVENTIS U.S. LLC | $124.33 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139581666 | CMS |
| SANOFI-AVENTIS U.S. LLC | $125.00 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139581664 | CMS |
| SANOFI-AVENTIS U.S. LLC | $125.00 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139581668 | CMS |
| SANOFI-AVENTIS U.S. LLC | $125.02 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139581670 | CMS |
| Xeris Pharmaceuticals, Inc. | $118.71 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144601315 | CMS |
| Xeris Pharmaceuticals, Inc. | $125.23 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144601317 | CMS |
| Xeris Pharmaceuticals, Inc. | $125.05 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144601319 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.